Navigation Links
Advertising to Consumers May Raise Drug Prices
Date:11/24/2009

With Plavix as an example, study finds no added use but higher costs

TUESDAY, Nov. 24 (HealthDay News) -- Direct-to-consumer drug ads may contribute to higher Medicaid costs, according to a new study that examined sales of the widely used antiplatelet drug clopidogrel (Plavix).

The analysis of data from 1999 to 2005 for 27 state Medicaid programs found that direct-to-consumer advertising for clopidogrel did not increase people's use of the drug but appeared to be associated with increased drug costs and Medicaid pharmacy expenditures.

Consumer ads for clopidogrel began in 2001. Between then and 2005, spending on DTCA for clopidogrel in the United States was more than $350 million, an average of $70 million a year. In that same time frame, use of the drug in Medicaid programs did not increase, but cost per unit per quarter increased by 40 cents (12 percent), leading to an additional $40.58 in pharmacy costs per 1,000 Medicaid enrollees per quarter, the study found.

"Overall, this change resulted in an additional $207 million in total pharmacy expenditures," wrote Michael R. Law, of the Centre for Health Services and Policy Research at the University of British Columbia in Vancouver, and his colleagues.

"Consequently, payers and policy makers should ... be concerned about [direct-to-consumer advertising] increasing total drug costs for publicly funded reimbursement programs such as Medicaid and Medicare," the researchers concluded. "Future longitudinal studies should examine other drugs and settings because many other countries are currently considering whether to permit" such ads.

The study is in the Nov. 23 issue of Archives of Internal Medicine.

More information

The U.S. Food and Drug Administration has more about direct-to-consumer drug ads.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Nov. 23, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pitt study finds inequality in tobacco advertising
2. CEOs Need an Advertising Check Up or Second Opinion
3. PCMA Launches New Round of E-Prescribing Advertising
4. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
5. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
6. Nurses Unveil New Advertising Campaign Against Schwarzenegger-Nunez Individual Mandate Plan
7. Renaissance Health Publishing, LLC Warns the Public that ConsumerLab.com is Not Independent and Labels the CL Seal of Approval a Worthless, Paid-For Advertising Gimmick
8. American Red Cross Launches 2008 National Public Service Advertising Campaign
9. St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards
10. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
11. CBS Outernet Partners With Lifeclinic International to Bring Interactive Health Programming and Advertising to Pharmacy Locations Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: